Treatment of heart failure with preserved ejection fraction
Submitted: April 24, 2018
Accepted: May 14, 2018
Published: June 7, 2018
Accepted: May 14, 2018
Abstract Views: 3283
PDF: 852
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Gian Francesco Mureddu, Cesare Greco, Stefano Rosato, Paola D'Errigo, Leonardo De Luca, Gabriella Badoni, Pompilio Faggiano, Fulvia Seccareccia, High thrombotic risk increases adverse clinical events up to 5 years after acute myocardial infarction. A nationwide retrospective cohort study , Monaldi Archives for Chest Disease: Vol. 89 No. 3 (2019)
- Angela Beatrice Scardovi, Renata De Maria, Gian Giacomo Galeotti, Pompilio Faggiano, Luca Arcari, Stefano Ghio, Pier Luigi Temporelli, Andrea Rossi, Giovanna Magni, Anca Simioniuc, Roberto Ricci, Frank Lloyd Dini, Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- Ravindra Nath, Neeraj Kumar Gupta, Amandeep Jaswal, Sparsh Gupta, Navjot Kaur, Santvana Kohli, Anirudh saxena, Pranav Ish, Rohit Kumar, Poornima Tiwari, Mukesh Kumar, Jugal Kishore, Geeta Yadav, Fellisha Marwein, Nitesh Gupta, Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Pompilio Faggiano, Francesco Fattirolli, Anna Frisinghelli, Lucrezia Piccioli, Nicolò Dasseni, Maria Vittoria Silverii, Laura Albricci, Giuseppe D'Ambrosio, Rosaria Garrì, Luigi Esposito, Francesco Giallauria, Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- Marie Christine Iliou, Jean Christophe Blanchard, Aurélia Lamar-Tanguy, Pascal Cristofini, François Ledru, Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators , Monaldi Archives for Chest Disease: Vol. 86 No. 1-2 (2016): Cardiac series
- Ugo Corrà , Cardiopulmonary exercise testing in systolic heart failure: from basic to advanced practice , Monaldi Archives for Chest Disease: Vol. 86 No. 1-2 (2016): Cardiac series
- Immacolata Ambrosino, Elena Barbagelata, Elena Ortona, Anna Ruggieri, Grace Massiah, Orazio Valerio Giannico, Cecilia Politi, Anna Maria Moretti, Gender differences in patients with COVID-19: a narrative review , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Raffaele Griffo, Cardiovascular Prevention and Coronary Heart Disease mortality decrease , Monaldi Archives for Chest Disease: Vol. 62 No. 2 (2004): Cardiac series
- P. Santus, L. Bassi, A. Airoldi, F. Giovannelli, D. Radovanovic, Varenicline and evaluated outcomes in smoking cessation programmes , Monaldi Archives for Chest Disease: Vol. 79 No. 1 (2013): Pulmonary series
- M. Lusuardi, G. Garuti, M. Massobrio, L. Spagnolatti, S. Bendinelli, Heart and Lungs in COPD. Close friends in real life - separate in daily medical practice? , Monaldi Archives for Chest Disease: Vol. 69 No. 1 (2008): Pulmonary series
<< < 30 31 32 33 34 35 36 37 38 39 > >>
You may also start an advanced similarity search for this article.